Management of Nausea and Vomiting Quiz

Ondansetron is a serotonin antagonist that helps alleviate chemotherapy-induced nausea and vomiting.

Antihistamines target Histamine H1 receptors to mitigate motion sickness-induced nausea and vomiting.

QT prolongation is a potential side effect of ondansetron, a serotonin antagonist.

The use of regional anesthesia is not typically associated with an increased risk of postoperative nausea and vomiting (PONV).

Common adverse effects of scopolamine transdermal patches for motion sickness prevention include dry mouth, blurred vision, and drowsiness.

Metoclopramide acts as a dopamine receptor antagonist, enhancing gastrointestinal motility.

Hypertension is not a typical side effect of serotonin antagonists used for nausea and vomiting.

Doxylamine and pyridoxine combination is the recommended first-line treatment for morning sickness in pregnant women.

Ondansetron is considered safe for use in children as an antiemetic medication.

Ginger exerts antiemetic effects by inhibiting serotonin in the GI tract and central nervous system.

Increased physical activity is not a typically recommended non-pharmacological intervention for nausea and vomiting in palliative care.

Corticosteroids enhance antiemetic effects in chemotherapy-induced nausea and vomiting, but the exact mechanism is unknown.

Combination therapy with an NK1 receptor antagonist and a glucocorticoid is often considered for refractory nausea and vomiting.

The primary concern with scopolamine transdermal patches is the risk of anticholinergic side effects.

NK1 receptor antagonists are specifically effective for delayed chemotherapy-induced nausea and vomiting.